Skip to content

Bimatoprost

DRUG20 trials

Sponsors

Region Vaesterbotten, Allergan, Innovative Medical, Summa Health System, University of Parma

Conditions

AlopeciaAlopecia, AndrogeneticAndrogenetic AlopeciaApplication Site Pigmentation ChangesBaldnessBurn ScarBurns LaserCicatrix

Early Phase 1

Phase 1

Phase 2

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
CompletedNCT00300443
AllerganOcular Hypertension
Start: 2005-12-31End: 2007-06-30Updated: 2011-05-30
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
CompletedNCT01291108
AllerganGlaucoma, Open-Angle, Ocular Hypertension
Start: 2011-04-30End: 2011-10-31Updated: 2013-11-06
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
CompletedNCT01915940
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2013-10-23End: 2014-11-14Updated: 2018-04-20
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
CompletedNCT02143843
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2014-06-05End: 2016-01-31Updated: 2019-02-26
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
CompletedNCT02170662
Duke UniversityAndrogenetic Alopecia, Male Pattern Hair Loss
Start: 2009-11-30End: 2011-05-31Updated: 2014-09-05
Dose-Ranging Study of the Bimatoprost Ocular Insert
CompletedNCT02358369
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2015-01-19End: 2015-10-07Updated: 2020-06-04
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
CompletedNCT02537015
ForSight Vision5, Inc.Ocular Hypertension, Primary Open-Angle Glaucoma
Start: 2015-08-10End: 2016-08-11Updated: 2019-04-02
Treatment of Hypopigmented Scars With Bimatoprost
RecruitingNCT06122090
Medstar Health Research InstituteBurn Scar, Burns Laser, Cicatrix +6
Start: 2023-07-18End: 2025-07-31Target: 25Updated: 2024-05-03

Phase 3

Phase 4

Unknown Phase

Related Papers